SFFS
NVAX icon

Stonehage Fleming Financial Services’s Novavax NVAX Stock Holding History

Stonehage Fleming Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Hold
18,705
– – 0.01% 149
2026
Q1 		$152K Hold
18,705
– – 0.01% 158
2025
Q4 		$126K Buy
+18,705
New +$141K ﹤0.01% 163

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Stonehage Fleming Financial Services's NVAX Position: Q2 2026 in Review

Stonehage Fleming Financial Services held its Novavax (NVAX) position steady in Q2 2026 at 18,705 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #149.

Stonehage Fleming Financial Services first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Stonehage Fleming Financial Services held 18,705 shares of Novavax worth $176K as of Q2 2026.
  • Stonehage Fleming Financial Services left its Novavax share count unchanged in Q2 2026.
  • Novavax made up 0.01% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #149 holding.
  • Stonehage Fleming Financial Services first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.